L1TD1 (LINE-1 type transposase domain containing 1), also known as FLJ10884 or ECAT11 (embryonic stem cell-associated transcript 11), is a protein that in humans is encoded by the L1TD1 gene. This protein is implicated in the regulation of pluripotency in embryonic stem cells (ESCs) and has a role in stem cell maintenance.The L1TD1 protein has a domain that is similar to the enzymatic core of certain LINE-1 (L1) transposases. LINE-1 elements are retrotransposons, which are sequences of DNA that can change their position within the genome, potentially creating or reversing mutations and altering the genome's size and composition. Although L1TD1 contains this domain, it is not known to function as a transposase in humans; the transposase activity is typically lost in such domesticated genes that gain a function beneficial to the organism.
L1TD1 is highly expressed in human embryonic stem cells and is thought to be essential for maintaining their pluripotent state-a condition where cells have the potential to differentiate into any type of cell in the body. The protein is one of the factors used to characterize undifferentiated ESCs and is involved in the regulation of gene expression in these cells. Its role in pluripotency is emphasized by its interaction with key pluripotency factors, such as NANOG, OCT4, and SOX2, which are crucial for the self-renewal and differentiation potential of ESCs.In addition to its association with stem cells, the L1TD1 gene is also interesting because it represents a case of a "domesticated" gene, which is a gene found in a transposable element that has evolved to acquire a new function in the host organism. The study of L1TD1 and similar genes can provide insights into gene evolution and the complex regulation of stem cell biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may inhibit L1TD1 expression by intercalating into DNA, inhibiting RNA synthesis and affecting transcription of L1TD1. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide might inhibit L1TD1 expression by blocking protein synthesis, thereby reducing the production of L1TD1 protein. | ||||||
Chromomycin A3 | 7059-24-7 | sc-200907 | 10 mg | $260.00 | ||
Actinomycin C could potentially inhibit L1TD1 expression similarly to Actinomycin D, by interfering with RNA synthesis. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin may inhibit L1TD1 expression by targeting bacterial-like RNA polymerase, potentially affecting the transcription of L1TD1. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin might inhibit L1TD1 expression by prematurely terminating protein synthesis, thereby reducing L1TD1 production. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin has been suggested to inhibit L1TD1 expression by inhibiting protein synthesis at the translational level, affecting L1TD1 production. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin may inhibit L1TD1 expression by intercalating into DNA and impacting transcription, reducing the synthesis of L1TD1. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide could potentially inhibit L1TD1 expression by affecting topoisomerase II activity, influencing DNA transcription and L1TD1 synthesis. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $367.00 $520.00 | 20 | |
Blasticidin S may inhibit L1TD1 expression by interfering with protein synthesis, potentially reducing the production of L1TD1. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C might inhibit L1TD1 expression by crosslinking DNA, affecting transcription and potentially reducing L1TD1 synthesis. | ||||||